Clinical Trials Logo

Clinical Trial Summary

Regular bronchial clearance is essential in patients with cystic fibrosis for their bronchial health. SIMEOX® (Physio-Assist, Aix en Provence, France) is an innovative medical device for the drainage of the bronchial tree. By changing the rheological properties of mucus, SIMEOX® helps to mobilize secretions and assists their transport to the upper airways. This technology is based on fundamental research on bronchial mucus rheology. At the present time, SIMEOX® device is mainly used over a short period at the time or after an exacerbation in healthcare structures (hospitals, physiotherapy practices, postcare, and rehabilitation units, etc…). The clinical effects observed in the short term encourages long-term autonomous use by the patients themselves. The overall objective of this study is to evaluate the efficiency and acceptability of SIMEOX® used at home by the patient himself for bronchial clearance in patients with cystic fibrosis.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04095078
Study type Interventional
Source Physio-Assist
Contact
Status Completed
Phase N/A
Start date March 10, 2020
Completion date December 15, 2021

See also
  Status Clinical Trial Phase
Completed NCT02566044 - Safety, Pharmacokinetics and Pharmacodynamics Study of Inhaled QBW276 in Patients With Cystic Fibrosis Phase 1/Phase 2
Recruiting NCT04700358 - Characterization of Antibacterial Antibodies in Patients With Cystic Fibrosis
Recruiting NCT04157361 - Pulmonary Condensate: Non-invasive Evaluation of Pulmonary Involvement in Asthma and Cystic Fibrosis.
Recruiting NCT04096664 - Home Airway Clearance in CF Patients N/A
Completed NCT02781610 - Standardized Treatment of Pulmonary Exacerbations II Phase 4
Completed NCT02853175 - Lung MRI and Allergic Broncho-pulmonary Aspergillosis in Cystic Fibrosis